Introduction
Redirecting adenovirus (Ad) vectors to specific cell types has become a major challenge in recent years. 1 Restricting gene delivery to a desired cell population indeed constitutes a promising approach to increase both the safety and efficacy of adenovirus-mediated gene transfer in vivo. First, systemic or loco-regional injections are likely to be safer, due to an abolished or reduced virus uptake by non-target tissues. For example, cellular binding and internalization of Ad5-based vectors typically trigger a cascade of signaling events, including upregulation of NFkB, IL-8 or various chemokines, [2] [3] [4] [5] [6] [7] which likely contribute to the acute inflammatory and injury responses that characterize this class of vector in vivo. [2] [3] [4] Second, targeted vectors are likely to be less immunogenic provided their uptake by antigen-presenting cells (APCs) is significantly reduced as proposed. 8 Finally, it is widely recognized that systemic administration of Ad5-based vectors results in a rapid and almost exclusive transduction of the liver in mammals, preventing efficient delivery of the therapeutic transgene to other compartments. [9] [10] [11] [12] The ability to genetically control the virus tropism in vivo will certainly expand the use of adenoviral vectors beyond loco-regional administrations in humans. The coxsackie and adenovirus receptor (CAR) has been previously identified as high-affinity attachment receptors for Ad5-based vectors. 13, 14 Virus binding to the cellular surface is followed by its internalization in clathrin-coated vesicles, an event that is mediated by the specific recognition of an RGD motif in the penton base by av integrins. 15, 16 The deciphering of the intimate structure of the viral capsid, together with a thorough understanding of the virus-cell molecular interactions [17] [18] [19] [20] [21] [22] has opened the way to the development of capsidmodified adenoviruses displaying a novel tropism. In particular, several groups have recently demonstrated the permissivity of particular domains within the fiber and hexon proteins for functional presentation of small peptide ligands at the capsid surface, thereby extending the repertoire of cell types susceptible to Ad5 uptake and infection. [23] [24] [25] [26] [27] On the other hand, strategies aiming at abrogating the virus native tropism have proved more challenging. Whereas deleting the fiber gene from the adenoviral genome certainly appears as the most straightforward approach to circumvent virus attachment to the cell surface, this approach has met with limited success as the modified capsids were reportedly immature and unable to escape the endosome compartment once inside the cells. 28 Replacing the fiber gene of Ad5-based vectors with that from a serotype that does not recognize CAR for cell surface attachment (eg Ad3) has also been investigated so as to substitute the virus initial tropism with that of a different serotype rather than rationally restrict the infection to particular cell types. [29] [30] [31] [32] The high resolution of the knob-CAR crystal structure 18 has recently allowed the identification of non-linear CAR-binding sites within the knob, and has paved the way to more refined strategies relying on the selective modification of knob residues critical for attachment to CAR. 19, [33] [34] [35] [36] Recently, more prospective approaches based on the genetic replacement of the entire knob with a heterologous domain capable of eliciting fiber trimerization and specific binding to particular cell surface receptors have also been investigated. [37] [38] [39] Here we took a different pathway in an attempt to alter binding of Ad5 vectors to their target cells in vitro, and most importantly in vivo. More specifically, we wondered to what extent the distance to which the knob protrudes from the capsid surface might dictate the modalities of virus attachment and uptake. Indeed, comparison of the fiber length from different human adenoviruses and their cell binding specificities allows one to classify them into three categories: members from subgroup A (eg Ad12) and C (eg Ad5) display extended fibers (37 nm in length for Ad5) and use CAR for cell surface attachment. 40 On the contrary, members from subgroup B (eg Ad3) display the shortest fibers (10 nm for Ad3), and attach to yet unknown receptors in a CAR-independent manner. 30, 32, 41 Members from subgroup D (eg Ad9) also display relatively short fibers (12 nm for Ad9) and seem to use CAR as attachment receptor only marginally. [42] [43] [44] We thus postulated that shortening the Ad5 fiber shaft, or replacing the fiber shaft and knob of Ad5 vectors with that from their Ad3 counterpart could significantly attenuate, and perhaps abrogate, their uptake by CARexpressing cells in vitro and in vivo.
Results

Construction and characteristics of mutant viruses
The Ad5 fiber is a homotrimeric protein containing an amino-terminal penton base attachment domain (tail), a long and thin central shaft consisting of 22 pseudorepeats of 15 amino acids and a carboxyl-terminal head called knob interacting with CAR. 45 To evaluate the impact of fiber shortening on Ad5 interaction with cells, we shortened the Ad5 shaft from 22 to 9 or 6 pseudorepeats to obtain respectively BS1 and BS2 viruses ( Figure 1 ). To understand better the respective contribution of fiber and penton base in the entry pathway of these short-fiber viruses, we further deleted the RGD peptide from the penton base of BS1 to generate AE73. As a control, AE74 was obtained by deleting the RGD peptide from the penton base of unmodified virus AE18. Finally, to investigate whether Ad3 fiber alone can confer to an Ad5 capsid an efficient CAR-independent entry pathway, DB6, containing a chimeric fiber resulting from the fusion of Ad5 tail to Ad3 shaft and knob, was constructed. All viruses were derived from E1-E3-deleted Ad5 genomes containing a CMV-lacZ expression cassette cloned in the E1 position. 46 The viral genomes were constructed by recombination in Escherichia coli 46 and transfected in PER.C6 cells. All corresponding viruses were viable while exhibiting different growth characteristics on these cells. High titer purified preparations of AE18, AE74 and DB6 (usually at least 10 12 viral particles per ml (VP/ml)) were obtained using standard procedures (purification from infected cells lysate by CsCl banding). BS1 and AE73 accumulated at low rate but normal yield in the supernatant of infected PER.C6 cells. Typically, titers as high as 10 10 VP/ ml were reached 7 days following an infection at a multiplicity of infection (MOI) of 100 VP/cell as compared to 4 days for control AE18 virus. The delay observed in the appearance of a full cytopathic effect prompted us to purify these viruses from the supernatant as detailed in Materials and methods. Finally, we were not able to grow BS2 at titers higher than 10 8 VP/ml in the supernatant of infected PER.C6 cells. Using the monoclonal antibody 1D6-14 specific for the trimeric form of the Ad5 fiber, 47 we evidenced that BS2 fiber trimerization occurred normally in infected cells (data not shown). Also, BS2 and DB6 contain very similar fibers in terms of length and shape, making it very unlikely that the BS2 fiber would be unable to stably anchor into the capsid. We thus suggest that BS2 growth defect results from a dramatically lowered capability to interact with CAR and so from its inability to efficiently propagate in PER.C6 cells.
DNA from all purified viruses was checked by restriction analysis and sequencing of the modified genes, and protein profile of all viruses was analyzed by Western blot using an anti-Ad5 polyclonal antibody ( Figure 2 ). The modified fibers of BS1, AE73 and DB6 could be evidenced at an apparent molecular weight close to the theoretical one (40.6 kDa for BS1 and AE73 and 34.8 kDa for DB6), and a Western blot using antibodies specific to the Ad5 fiber tail showed no difference in the amount of fiber incorporated in each virus (not shown). A difference in migration of wild-type and RGD-deleted penton base proteins was observed although the difference in the theoretical molecular weight was very low (63.2 versus 62.4 kDa). That the electrophoretic (Figure 2) or HPLC (not shown) profiles of BS1 capsids were unchanged as compared to AE18 suggests that shaft shortening did not critically interfere with capsid assembly and maturation steps necessary to allow subsequent effective entry into cells. Altered liver tropism of capsid-modified adenoviruses E Vigne et al
Virus titers were determined in transduction units (TDU) on the W162 simian reporter cell line 48 and in physical particles (VP) as determined by HPLC. 49 The UV spectrum (220-350 nm) of eluted viruses was monitored continuously during the HPLC procedure. We observed that the UV spectra were similar for all viruses (not shown) indicating that the quality of the virions was the same for all viral preparations. The VP/ TDU ratio of BS1 and AE73 were several orders of magnitude higher than for AE18 (Table 1) , which reflects the inability of both viruses to efficiently infect W162 cells. To compare the infection efficiency of the different viruses, all experiments were thus performed using physical particles concentration.
Infection of CAR-positive or -negative cells with modified viruses
To study the impact of the capsid modifications on the infectivity of the viruses, reporter transgene expression was measured in human CAR-and av integrins-positive 293 cells incubated for increasing times with the different viruses ( Figure 3a) . After a 24 h incubation, b-galactosidase activity following infection with BS1 was 40-fold lower than with the control virus AE18. Of note, all viruses bound very rapidly to their receptors in 293 cells, as a 30 min incubation was enough to reach bgalactosidase levels as high as 50% of those obtained following a 24 h incubation. DB6 efficiently transduced 293 cells, which are known to harbor high levels of Ad3 receptor(s), 50 demonstrating that this virus is fully infectious despite its chimeric fiber. In contrast, rat primary hepatocytes, which are known to express high levels of CAR 9 and with unknown status with regard to Ad3 receptor(s), were not effectively infected by DB6 when compared to AE18 (Figure 3b ). This evidenced that the tropism of this chimeric virus was different from that of the control virus.
A competition experiment in 293 cells (Figure 3c ) further showed that all viruses carrying an Ad5 knob were sensitive to Ad5 soluble knob competition (10-fold decrease of b-galactosidase activity after preincubation of cells with knob). These results were confirmed in other CAR-and av integrins-positive cell lines such as the human breast tumor MDA-MB-231 or the human prostate tumoral LNCaP cells (not shown), showing in particular that the knob remains the major player in the residual interaction between BS1 and these cells. Interestingly, RGD deletion from the penton base of AE18 resulted in a significant decrease in gene transfer (3.5-fold), whereas the same modification in BS1 did not further affect cell transduction, showing that the RGD motif in BS1 does not participate in 293 cells transduction.
To analyze the behavior of our viruses in the absence of any interaction with CAR, transduction by AE18, BS1, AE74 and AE73 was compared in the CAR-negative and av integrins-positive cell line L929 ( Figure 3d ). 51 At a multiplicity of infection of 10 000 VP/cell, gene transfer with the RGD-negative AE74 and AE73 viruses was slightly above the background, whatever the length of incubation time. In contrast, the control vector AE18 was able to achieve significant gene transfer at that high MOI, and increasing the incubation time from 1 to 48 h improved transduction by 5.6-fold. These results are consistent with a model where the RGD motif allows the binding of an Ad5 vector to the cellular surface in the absence of CAR. Interestingly, transduction by BS1 was reduced 10-fold after a short incubation, while a 48 h incubation could rescue this transduction defect. Thus, it appeared that the binding of BS1 penton base to its cellular target was weakened. Also, that BS1 was capable of transducing CAR-negative cells as efficiently as AE18 following a 48 h incubation period (Figure 3d ) supports that shaft shortening did not affect any characteristics of the virion required to allow efficient intracellular trafficking following internalization. Altogether, the transduction assays in 293 and L929 cells indicate that the interactions of BS1 with both cellular CAR and integrins were seriously disturbed.
In vitro binding of modified viruses to soluble CAR
To study the interaction between the modified viruses and CAR independent of other possible virus-cell interactions, soluble CAR (sCAR) was immobilized on nitrocellulose membranes and tested for its ability to bind to the different viruses ( Figure 4 ). As expected, the chimeric Ad5/3 virus DB6 did not bind sCAR. Interestingly, binding of BS1 was severely reduced (about 10-fold) as compared to the AE18 control virus. Not surprisingly, AE74 and AE73 bound sCAR as well as their respective control virus. This assay demonstrates that the decrease in 293 cell transduction with BS1 most Figure 2 Protein profiles of purified mutant viruses. 10 10 VP of CsClpurified viruses were subjected to a 10% Bis-Tris Nupage gel electrophoresis under denaturing conditions and transferred to a nitrocellulose membrane, before immunoblotting with an anti-Ad5 polyclonal antibody. Proteins IIIa and wild-type fiber comigrate in those electrophoresis conditions. Ad3*: chimeric Ad5/Ad3 fiber, wt: wild-type Ad5. Altered liver tropism of capsid-modified adenoviruses E Vigne et al likely originates from a less efficient CAR binding. In addition, it corroborates the results from the knob competition experiment showing that a residual interaction between BS1 and CAR still occurs and mediates BS1 entry into 293 cells.
Intravenous injection of modified viruses
Intravenous administration of Ad5-based vectors in mice results in preferential expression in the liver, which is also the prominent organ for CAR expression. 13 We investigated whether the receptors-binding defects of BS1 and DB6 correlated with a decrease in mouse liver transduction following intravenous administration. C57BL/6 mice were injected intravenously with 10 11 VP of AE18, BS1 or DB6 and killed 7 days post-injection. Analyses were focused on quantitative comparison of reporter gene transfer to the liver based on b-galactosidase activity measurements and viral DNA quantification. Livers from the BS1-and DB6-inoculated animals exhibited 10% of b-galactosidase activity as those inoculated with control virus AE18, while saline-injected animals exhibited background levels of activity (Figure 5a ). Interestingly, a similar decrease in viral DNA amount present in the liver was observed with both capsid-modified viruses (Figure 5b ), indicating that reduction in reporter transgene expression resulted primarily from a significant attenuation in liver gene transfer and not from an effect of the capsid modifications on the signaling pathways leading to transgene expression post-infection. Finally, a significant decrease in serum anti-Ad antibody titer was observed in the BS1-and DB6-injected animals (Figure 5c : OD 490 at 1/1000 
Discussion
In this study, we have investigated to what extent fiber shaft shortening, and fiber swapping, impact the tropism of Ad5-based vectors in vitro and in vivo. To this end, we genetically reduced the length of the fiber shaft of Ad5 (22 pseudo-repeats of 15 amino acids) to generate mutant viruses BS1 and BS2, which only retain 9 and 6 pseudorepeats, respectively. Importantly, BS1 could be grown to a particle titer similar to that of an otherwise isogenic control virus (AE18). Of note, a delay was observed in the time of progression to full cytopathic effect, consistent with the decreased infectivity of the virus. Indeed, BS1 was unable to efficiently transduce the lacZ reporter gene in monkey permissive W162 cells (Table 1) , as well as in the human CAR-and av integrins-positive 293 cells (Figure 3a ). This correlated with a marked reduction in BS1 ability to interact with the CAR cellular receptor (Figure 4 ). In sharp contrast to BS1, we were unable to grow BS2 to significant titers. In vitro data strongly suggest that the growth defect of BS2 primarily results from a dramatically disabled interaction between the capsid and its cell surface receptors, and not from a limited incorporation of BS2 short-shafted fibers within Ad5-based capsids. Roelvink et al previously hypothesized that Ad5 fiber shaft shortening could favor the capsid interaction with av integrins by enabling the penton base to get closer to the cell surface. 42 Our data do not support this hypothesis. Indeed, whereas, in agreement with previous studies, 15, 36, 52 the sole deletion of the RGD motif from the penton base of AE18 decreased lacZ specific activity 3.5-fold in 293 cells, this deletion from the BS1 capsid was not associated with any decrease in gene transfer (Figure 3a) . Also, infection of 293 cells by BS1 remained highly sensitive to competition with soluble knob (Figure 3c ), indicating that residual uptake of BS1 mainly occurred through its fiber knob. That penton base binding to cellular integrins is disabled in the context of short-shafted BS1 capsids was confirmed in a CAR-negative context. As shown in Figure 3d , the RGD deletion from the control AE18 virus virtually abolished gene transfer into L929 cells, indicating that transduction by a long-shafted Ad5 vector is mediated essentially by the RGD-integrins interaction in these cells. One hour incubation of L929 cells with BS1 led to a 10-fold lower lacZ specific activity as compared to AE18, indicating a disabled interaction between BS1 capsids and cellular integrins. Of note, increasing BS1 incubation time to 48 h restored a transduction efficiency comparable to that of AE18, whereas that of the RGD-deleted constructs remained at background levels.
Altogether, our in vitro data indicate that shortening the Ad5 fiber shaft weakens both fiber-CAR and penton base-integrins interactions. The molecular basis for this dual impairment remains to be fully understood. Recent studies have outlined the contribution of various parameters to the optimal efficiency of Ad5 infection. 40, 42, 44, 53, 54 For example, the short fiber of subgroup D Ad37 (eight pseudo-repeats long) has been shown to be rigid and straight, whereas those from Ad5 or Ad12 are typically bent, apparently because of the occurrence of two particular 'flexible pseudo-repeats' within their shaft. 41, 53, 54 Chiu et al have proposed that this rigidity could account for the decreased infectivity of a chimeric Ad5/37 virus for CAR-positive cells, by preventing the side of the Ad37 knob from contacting cellular -but not soluble -CAR. 54 Of note, this situation should not apply to BS1, its fibers remaining likely flexible due to the retention of the two 'flexible pseudo-repeats' in its shortened shaft. In another study, Shayakhmetov and Lieber reported that Ad5-based capsids displaying an Ad5 knob fused to an Ad9 shaft (another rigid short-shafted subgroup D serotype) do not efficiently bind and transduce cells expressing high levels of CAR or/and av integrins. 29 They raised the possibility that electrostatic repulsions between the negatively charged hexon HVR1 protruding loops and the acidic cell surface proteins could be favored by shaft shortening and thus prevent high-affinity binding of short-shafted capsids to cell surface. Here again, this hypothesis cannot be fully valid for BS1 in the light that its binding to immobilized soluble CAR (ie independent of its cell membrane environment) was profoundly impaired (Figure 4) .
We propose that shaft shortening may induce steric hindrance between the fiber knob and the penton base Figure 4 Binding of mutant viruses to soluble CAR. Soluble CAR was blotted on a nitrocellulose membrane. The blot was blocked in PBS-5% milk and then incubated overnight with 10 10 VP of the mutant viruses. Detection was performed as described in Materials and Methods. Ad3*: chimeric Ad5/Ad3 fiber, wt: wild-type Ad5.
Altered liver tropism of capsid-modified adenoviruses E Vigne et al RGD protruding motif, precluding each other from efficiently interacting with their cognate receptors (ie CAR and integrins respectively). Independent observations support this hypothesis: (i) comparison of penton base and fiber sequences from the Genbank database indicates that long RGD-containing loops within the penton base are restricted to group C serotypes (eg 99 residues in Ad5 and Ad2), and that they all display long fiber shafts (ie 22 pseudo-repeats); on the other hand, all serotypes with short CAR-binding fibers also display much shorter RGD loops (eg 57 residues in Ad9), (ii) comparison of the three-dimensional structure of soluble recombinant avb5 integrins bound to Ad12 or Ad2 capsids indicates that the length of the protruding RGD loop (36 residues for Ad12 versus 99 residues for Ad2) impacts the positioning of cellular integrins relative to the fiber knob, 22 and (iii) the crystal structure of the Ad12 knob-CAR complex demonstrated that the CAR binding Figure 5 Mouse liver uptake of the mutant viruses after intravenous delivery. C57BL/6 were injected intravenously with 10 11 VP of mutant and control viruses BS1, DB6 and AE18. At day 7, the animals were sacrificed and total DNA and proteins were extracted from liver samples. (a) b-galactosidase activity of protein extracts was quantified using a chemiluminescent assay (*Po0.003 versus AE18). (b) Genomic liver DNA was subjected to quantitative PCR for viral DNA quantification (*Po0.004 versus AE18). (c) Anti-adenovirus antibodies present in the serum at day 6 were quantified using an ELISA described in Material and Methods (*Po0.002 versus AE18). Results are the average for duplicate samples 7 sem.
Altered liver tropism of capsid-modified adenoviruses E Vigne et al site is located on the side of the knob, facing the penton base RGD loop. 18 Systemic delivery of Ad5-based vectors in mice invariably leads to preferential transduction of hepatocytes, which are known to express CAR to high levels. 10, 14, 55, 56 The pathway involved in this uptake is however complex and remains largely unknown. On the one hand, several reports suggest that fiber-CAR interactions are primarily responsible for the natural tropism of Ad5-based vectors for the liver. 32, 57, 58 On the other hand however, systemic injection of Ad5 mutant viruses in which the knob could no longer interact with CAR in vitro did not result in a significant decrease of liver uptake in mice, leading to the hypothesis that liver uptake of Ad5 vectors indeed proceeds through a nonspecific, CAR-independent, entry pathway, 34, 35 or involves a synergy between CAR-and integrin-dependent pathways. 36 Based on this latter study, Einfeld et al have suggested that a dual strategy aiming at the simultaneous ablation of both entry pathways should be considered to efficiently circumvent liver uptake of Ad5 vectors in vivo. 36 In consistency with this hypothesis, we show here that indeed, the reduced ability of BS1 to bind CAR and integrins ( Figures 3 and 4) correlates with a significant (10-fold), although partial, decrease of liver uptake in vivo ( Figure 5 ). We believe that the residual uptake of BS1 by the liver can be primarily ascribed to an incomplete impairment of its binding to CAR, and not to an integrindependent pathway. Indeed, we did not observe any further decrease in liver transduction following intravenous administration of the AE73 virus (ie the BS1 virus deleted from the penton base RGD motif) (data not shown). Of particular relevance here, the complete ablation of Ad5-CAR interaction following fiber substitution with that from a non-CAR-binding fiber (virus DB6) led to a similar 10-fold decrease in liver transduction. The inability of DB6 to efficiently transduce the liver in mice cannot be simply explained by a general loss of infectivity as supported in vitro by the high transduction efficiency of DB6 for 293 cells. Also, that DB6 could not efficiently transduce primary rat hepatocytes in vitro (Figure 3b ) indeed suggests that rodent hepatocytes may not express the Ad3 receptor(s). Because liver uptake of CAR-ablated Ad5 vectors is not impaired, 34, 35 it seems possible that DB6 exhibits an additional defect, such as a weakened interaction with cellular integrins as for BS1. Alternatively, the possible involvement of several Ad5 attachment receptors in the mouse liver may explain why the complete ablation of the knob-CAR interactions by selective mutagenesis cannot completely abrogate capsid binding to the cellular surface, whereas shaft shortening, or fiber swapping, could be more effective in circumventing liver uptake in vivo.
Remarkably, systemic delivery of BS1 and DB6 viruses in mice was associated with a significant decrease in vector-specific serum antibodies (Figure 5c ). Transduction of dendritic cells following intramuscular or intravenous delivery of adenoviral vectors in mice has been previously documented. 8, 59, 60 These antigen-presenting cells can activate antigen-specific T cells and Blymphocytes (for a review, see Ref. 61 ). Accordingly, it is therefore possible that the lower receptors binding activity that characterizes BS1 and DB6 translates into a reduced infection of dendritic cells in vivo, leading to a reduced B cell host response thereby blunting the production of vector-specific antibodies.
Overall, our data support that genetic engineering of the fiber can be effectively used to cripple the interaction of Ad5 vectors with their two cell surface receptors in vitro and in vivo. Interestingly, that 293 cells, which display both Ad5 and Ad3 receptors, are equally permissive to DB6 and AE18 transduction indicates that a short fiber is not per se incompatible with an efficient entry of an Ad5 capsid. Successful retargeting of BS1 by genetic addition of peptide ligands into permissive capsid sites [23] [24] [25] [26] [27] should therefore be feasible provided the targeting moiety is positioned in such a way that it can efficiently contact its cognate receptor in a short fiber context. These strategies may prove useful in the future for the control of adenoviral tropism in vivo.
Materials and methods
Cell culture
The 293 cell line (CRL1573, American Type Culture Collection, Rockville, MD, USA) was maintained in modified Eagle medium (MEM) supplemented with 10% FCS. The PER.C6 cell line (Introgene/Crucell, Leiden, NL) was cultivated in high-glucose Dulbecco MEM (DMEM) supplemented with 10% FCS, 10 mM MgCl 2 and 1% glutamine. W162 is a cell line from monkey origin 62 and was grown in DMEM supplemented with 10% FCS. Rat primary hepatocytes were kindly provided by Dr C Gianini (Institut Pasteur-Necker, Paris, France). L929 murine fibrosarcoma cells were obtained from Dr U Greber (Institute of Molecular Biology, Zurich, Switzerland) and maintained in DMEM supplemented with 10% FCS.
Adenoviral vectors
AE18 is derived from Ad5 and deleted for both the E1 and E3 regions. 46 The expression cassette cloned instead of the E1 region contains the promoter/enhancer from the immediate early gene of human cytomegalovirus (CMV), the E. coli b-galactosidase gene with a nuclear localization signal, and the SV40 late polyA signal. All modified viruses were constructed using recombinational cloning in E. coli.
46 BS1 and BS2 are short fiber backbones deleted for the shaft pseudo-repeats 4-16 and 4-19, corresponding to Ad5 fiber amino acids 97-298 and 356 respectively. DB6 contains a chimeric Ad5-Ad3 fiber, where Ad5 shaft and knob (amino acids 47-581) are replaced with Ad3 shaft and knob (amino acids 46-319). AE74 and AE73 are derived from AE18 and BS1 respectively by deletion of the RGD motif from the penton base: the penton base sequence H 337 AIR-GDTFAT 346 was replaced by a threonine-serine motif. Following transfection of plasmid backbones in PER.C6 cells, the viruses AE18, DB6 and AE74 were generated, amplified and purified from cell lysates by two successive CsCl ultracentrifugation steps. 63 BS1 and AE73 exhibited delays in the time of progression to full cytopathic effect but accumulated at normal yields in the supernatant of infected PER.C6 cells. Whatever the virus amplified, PER.C6 cells were infected at MOI 100 VP/cell. Supernatant was concentrated by a tangential flow filtration step using a Pellicon 2 Module (Millipore, Bedford, MA, USA) and the virus present in Altered liver tropism of capsid-modified adenoviruses E Vigne et al the concentrate was further purified by two successive CsCl ultracentrifugation steps. All viruses were aliquoted and stored in Tris 20 mM pH 8.4-10% glycerol at À201C. Viral particles concentrations were quantified by HPLC. 49 Infectious titers were determined as transduction units (TDU) 48 h post-infection of monkey W162 cells using X-Gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside) staining. 48 Analysis of protein profile of purified viruses 10 10 VP of purified viruses were resuspended in 1 Â loading buffer, denatured by 5 min boiling and loaded onto a 10% NuPage gel (Novex). The gel was transferred onto a nitrocellulose membrane in semi-dry conditions and Western blot analysis was performed according to the ECL protocol (Amersham) with L5 antibody, a rabbit polyclonal antibody raised against AE18 and recognizing the whole Ad5 virion components.
In vitro binding to sCAR 0.5 and 0.05 mg of soluble CAR (a kind gift from D Curiel, University of Alabama, Birmingham, AL, USA) were blotted onto a nitrocellulose membrane. After blocking for 1 h in phosphate-buffered saline (PBS)-5% milk, the membrane was incubated with 10 9 or 10 10 VP in PBS-0.5% milk at 41C overnight. After two washes in PBS-0.5% milk-0.05% Igepal CA-630 (Sigma, France), the blot was further incubated with a 1/2000 dilution of the L5 antibody for 2 h at room temperature, washed twice, and incubated with a 1/100 000 dilution of a goat anti-rabbit secondary antibody conjugated to horseradish peroxyidase (Jackson ImmunoResearch, West Grove, PE). The blot was finally revealed using the ECL Western blot detection kit (Amersham).
In vitro transduction assays
For competition experiments, cell monolayers were preincubated 30 min at room temperature with PBS or 10 mg/ml of purified recombinant Ad5 knob (a kind gift from D Curiel), before addition of the virus. Thirty minutes later, cells were washed twice with PBS and further incubated for 24 h at 371C with fresh medium. 293 cells and rat primary hepatocytes were infected at an MOI of 5 and 100 VP/cell respectively. For kinetics experiments, 293 and L929 cells were incubated with viruses for increasing times and washed twice with PBS. Fresh medium was added and b-galactosidase activity of the whole cell extract was quantified 24 or 48 h postinfection in a chemiluminescent assay (Clontech, Palo Alto, CA, USA). Protein concentration was determined using the Bio-Rad Protein Assay.
Animal experiments
10
11 VP of control or modified virus were injected in the retro orbital plexus of 7-week-old C57BL/6 mice (Janvier and IFFA-CREDO, France). Six days post-injection, blood samples were collected and sera analyzed for the presence of anti-Ad antibodies by ELISA. 64 Animals were sacrificed 7 days following injection and livers were removed. 50 mg of liver tissue sample was placed in lysing matrix tubes containing 1 ml of suitable buffer and homogenized via the FastPrep System (FP120, Bio 101 Savant). Resulting homogenates were clarified by centrifugation at 14 000 g for 15 min at 41C. For protein extraction, the lysis buffer was 0.2% triton X-100, 0.5 mM DTT, 100 mM potassium phosphate and one Complete TM protease inhibitor cocktail tablet (Boehringer Mannheim) per 50 ml of buffer. After centrifugation, the supernatant was measured for b-galactosidase activity using a chemiluminescent assay (Clontech, Palo Alto, CA, USA). Protein content was determined by the Bio-Rad Protein Assay. For DNA extraction, the Promega Wizard genomic DNA Purification Kit Nuclei Lysis Solution was used as lysis buffer. After centrifugation, total DNA was recovered according to the manufacturers instructions. Absorbances at 260 and 280 nm were measured and after proper dilution, 50 ng of genomic DNA was subjected to quantitative PCR in duplicate samples.
Quantitative PCR
To quantify the amount of viral DNA present in liver samples, real-time PCR was performed using the ABI Prism 7700 system and buffers provided by the manufacturer (Perkin-Elmer Applied Biosystems, Foster City, CA, USA). The primers (sense: 5 0 -YCC CAT GGA YGA GCC CAC MCT-3 and antisense 5 0 -GAG AAS GGB GTG CGC AGG TAS-AS-3 0 ) and the fluorogenic probe (5 0 -CAC CAG CCA CAC CGC GGC GTC ATC GA-3 0 ) are located in the hexon gene (Y¼C or T, M¼A or C, S¼G or C, and B¼C or G or T) (Saulnier et al, manuscript in preparation). The probe was linked at its 5 0 terminus with a reporter dye (6-carboxyfluorescein) and with a quencher dye (6- carboxy-N, N, N 0 , N 0 -tetramethylrhodamine) at its 3 0 end. One microgram of human and murine genomic DNA (Roche Molecular Biochemicals, Meylan, France) were used to show the specificity of the Ad5 PCR. Samples were submitted to 50 PCR cycles with continuous monitoring of the fluorescence.
Statistical analysis
All in vivo data are shown as mean 7 standard error of the mean (sem) and statistical analysis was performed using the Mann-Whitney test. Threshold for significance was set to P¼0.05.
